Skip to content

Clinical trials

Generalized Anxiety Disorder trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Country / region: France Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20081
20151
20161
20221
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris1
Assistance Publique Hopitaux De Marseille1
AstraZeneca1
Centre Hospitalier Régional d'Orléans1
Centre Hospitalier Universitaire de Saint Etienne1
Definium Therapeutics US, Inc.1
H. Lundbeck A/S1
Maastricht University Medical Center1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder11
Anxiety Disorders4
Alcoholism1
Depressive Disorder1
Drug Resistant Epilepsy1
Epilepsies, Partial1
Major Depressive Disorder1
Marijuana Abuse1
Neoplasms1
Parkinson Disease1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.